PharmaBlock Sciences (Nanjing), Inc.

  • Market Cap: Mid Cap
  • Industry: Miscellaneous
  • ISIN: CNE1000035K5
CNY
34.50
0.14 (0.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
PharmaBlock Sciences (Nanjing), Inc.

Why is PharmaBlock Sciences (Nanjing), Inc. ?

1
With ROE of 5.33%, it has a fair valuation with a 2.62 Price to Book Value
  • Over the past year, while the stock has generated a return of -2.29%, its profits have risen by 23.2% ; the PEG ratio of the company is 2.1
  • At the current price, the company has a high dividend yield of 0.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to PharmaBlock Sciences (Nanjing), Inc. should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PharmaBlock Sciences (Nanjing), Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
PharmaBlock Sciences (Nanjing), Inc.
-2.29%
0.41
45.85%
China Shanghai Composite
15.17%
1.02
14.86%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.48%
EBIT Growth (5y)
-0.18%
EBIT to Interest (avg)
36.57
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.36
Tax Ratio
10.97%
Dividend Payout Ratio
25.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.85%
ROE (avg)
11.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
2.62
EV to EBIT
44.86
EV to EBITDA
26.83
EV to Capital Employed
2.72
EV to Sales
5.05
PEG Ratio
2.12
Dividend Yield
0.50%
ROCE (Latest)
6.07%
ROE (Latest)
5.33%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 685.95 MM

NET SALES(HY)

At CNY 964.04 MM has Grown at 28.46%

DEBT-EQUITY RATIO (HY)

Lowest at -10.19 %

INVENTORY TURNOVER RATIO(HY)

Highest at 1.73 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.22 times

-8What is not working for the Company
ROCE(HY)

Lowest at 4%

INTEREST COVERAGE RATIO(Q)

Lowest at 329.84

RAW MATERIAL COST(Y)

Grown by 12.95% (YoY

OPERATING PROFIT(Q)

Lowest at CNY 32.52 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.51 %

PRE-TAX PROFIT(Q)

At CNY 40.34 MM has Fallen at -28.23%

Here's what is working for PharmaBlock Sciences (Nanjing), Inc.

Operating Cash Flow
Highest at CNY 685.95 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales
At CNY 964.04 MM has Grown at 28.46%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio
Lowest at -10.19 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 1.73 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 5.22 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for PharmaBlock Sciences (Nanjing), Inc.

Interest Coverage Ratio
Lowest at 329.84
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 32.52 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 6.51 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
At CNY 40.34 MM has Fallen at -28.23%
over average net sales of the previous four periods of CNY 56.21 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Raw Material Cost
Grown by 12.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at CNY 0.41 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income